[Registry of Inborn errors of immunity in a pediatric hospital]

Miguel García-Domínguez1, Guadalupe Carmen Valero-Gálvez, Carlos Alberto Velázquez-Ríos

  • 1Secretaría de Salud del Estado de Sinaloa, Hospital Pediátrico de Sinaloa, Departamento de Inmunología Clínica, Sinaloa, México. miguelgarcia.alergia@gmail.com.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|February 26, 2021
PubMed

Insights

The Pediatric Hospital of Sinaloa diagnosed and treated twelve cases of inborn errors of immunity (IEI) from 2017. Predominantly antibody deficiency was most common, with significant mortality from sepsis and hemorrhage.

Area of Science:

  • Pediatric Immunology
  • Clinical Genetics
  • Public Health

Background:

  • The Pediatric Hospital of Sinaloa joined the Latin American Society for Immunodeficiencies (LASID) registry in 2017.
  • This affiliation aimed to track patients with primary immunodeficiency or inborn errors of immunity (IEI).

Observation:

  • Twelve IEI cases were diagnosed and treated between 2017 and the study period.
  • Patient ages ranged from two days to sixteen years, with symptom onset between nineteen days and four years.
  • A male predominance (67%) was observed among diagnosed patients.

Findings:

  • Predominantly antibody deficiency was the most frequent IEI (33.3%).
  • Other diagnosed IEIs included phagocyte defects, autoinflammatory disorders, and combined immunodeficiencies.
  • 84% received intravenous immunoglobulin; one patient with Wiskott-Aldrich syndrome had a WAS gene variant identified.
  • One patient underwent hematopoietic stem cell transplantation.
  • Mortality was 33.3%, with sepsis (25%) and hemorrhage (8.3%) as primary causes.

Implications:

  • The IEI registry provides crucial epidemiological data for developing targeted health policies.
  • Improved data collection can lead to better resource allocation and enhanced care models for IEI patients.
  • This study highlights the need for early diagnosis and comprehensive management strategies for inborn errors of immunity.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
578
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
519
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
101
Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
6.8K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
80.4K